An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results
Clinical trial NCT05640180 · COMPLETED
Trial details
- NCT number
- NCT05640180
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-23
- Primary completion
- 2023-12-20
- Enrollment
- 17847
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.